RecruitingNCT06306118

Autoguide Positioning Device for Multiple Stereotactic Biopsies

Application of the Autoguide® Positioning Device for Multiple Stereotactic Tumor Biopsies During a Brain Tumor Resection


Sponsor

Medical University of Graz

Enrollment

25 participants

Start Date

Apr 15, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this clinical study should be that, in the context of planned resections of glial brain tumors, pieces of tissue (biopsies) are removed from the tumor at several specific locations before the actual tumor resection takes place. The aim of these biopsies in advance to the actual tumor resection will be to receive tumor tissue samples not altered in such a way that it is no longer adequate for further treatment. If not adequate, a so-called "undergrading" could occur, which means that the biological structure of the tumor is misjudged and further therapy does not achieve the desired effect in the patient. On the one hand, certain tumor regions can drift due to a "brain shift" which leads to inaccurate tissue removal, and on the other hand samples are not altered by pressure or bleeding. To carry out these biopsies, a robot positioning device (AutoGuide®) will be used that has already been approved and tested for this type of intervention. The use of the AutoGuide® is intended to ensure that the tumor sample is taken with the greatest possible precision.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria4

  • Age 18-80 years
  • Diagnosis of a cerebral lesion with the indication for surgical resection
  • Written informed consent to participate in the present study
  • MRI and CT scanner compatibility

Exclusion Criteria4

  • Pregnancy, breast feeding
  • Patients not able to reason
  • Age \<18 or \>80 years
  • Claustrophobia

Interventions

DEVICEMultiple stereotactic Tumor Biopsies during a Brain Tumor Resection

For pre-resection biopsy cases (3 target per patient), the targets will be selected from metabolite hotspots on MR-spectroscopy imaging and/or amino acid tracer uptake hotspots on PET imaging. Depending on the tumor location and surgical procedure, all biopsies will be performed via one single or multiple entry points.


Locations(1)

Medical University of Graz

Graz, Styria, Austria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06306118